Myrsine coriacea subsp. coriacea
Myrsine coriacea subsp. coriacea · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Myrsine coriacea subsp. coriacea is a distinctive botanical specimen known for its unique chemical composition. Scientific investigations have identified the presence of specific bioactive compounds, such as Myrsinoic acid B, within its structure. Research often focuses on the plant's stem as a primary source for valuable medicinal properties. By utilizing ethanolic extracts of the stem barks, researchers can effectively isolate these significant secondary metabolites. Understanding these chemical profiles provides essential insights into the plant's potential pharmacological applications.
- Synonyms
- Rapanea Paulensis · Rapanea Ambigua · 39 more
- Common names
- Not available
- Family
- Primulaceae
- Distribution
- Not available
- Plant Parts
- Stem
Classification
Common Names
Myrsine coriacea subsp. coriacea is a versatile plant recognized by a variety of regional names across different landscapes. It is widely known by the common name Arrayan, a title that highlights its botanical identity. In certain areas, the species is also referred to as Bois plomb or Bois sand. Local traditions in Haiti frequently identify the plant as Bois savane. Furthermore, it is occasionally called Bois saane, illustrating the diverse linguistic heritage associated with this single subspecies.
Sources: Catalogue of Life (COL)
Synonyms
Myrsine coriacea subsp. coriacea is a botanical subject characterized by a complex history of taxonomic synonymy. Throughout various scientific classifications, this plant has been identified under several alternative names, including Ardisia coriacea var. berteroana and Ardisia guadeloupensis. Researchers have also documented it under the names Caballeria ferruginea and Icacorea guadalupensis in different historical contexts. Furthermore, the species is linked to the synonym Manglilla ferruginea, highlighting the evolving nature of its botanical identity. Understanding these overlapping designations is essential for accurate identification and study within its natural habitat.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Myrsine coriacea subsp. coriacea belongs to the vast kingdom Plantae, representing a distinct branch of the natural world. As a member of the class Equisetopsida, this subspecies follows a specific evolutionary lineage within the plant kingdom. It is further categorized under the order Ericales, which connects it to a diverse group of flowering plants. Within this order, it sits firmly inside the family Primulaceae, sharing characteristics with its botanical relatives. Finally, it is classified under the genus Myrsine, which defines its unique morphological identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Primulaceae |
| Genus | Myrsine |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Myrsine coriacea subsp. coriacea maintains an expansive presence throughout various regions of Northern America. Within Mexico, this subspecies is widely distributed across several distinct geographical zones. Its range encompasses the central territories as well as the coastal influences of the Gulf region. Furthermore, the plant can be found stretching into the Northeast, Northwest, and Southeast portions of the country. This widespread availability highlights the adaptability of the subspecies across diverse Mexican landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Compounds
Myrsine coriacea subsp. coriacea serves as a significant subject in the search for new antiparasitic agents. Within this plant, the presence of myrsinoic acid B has been identified as a key component. This specific isolated compound demonstrated notable activity against Leishmania brasiliensis during laboratory testing. Such findings highlight the potential medicinal value found within the stem barks of this species. Ultimately, the study suggests that these botanical resources are promising candidates for developing effective treatments against parasitic infections.
Conditions
Myrsine coriacea subsp. coriacea, represented in the study by the related taxon Rapanea ferruginea, demonstrates significant antileishmanial activity against the parasite L. brasiliensis. Specifically, the ethanolic extracts derived from the stem barks of this plant were tested for their efficacy against the pathogen. The results indicated an IC50 value of 24.1 μg/mL when treating the L. brasiliensis strains. Furthermore, the isolated compound myrsinoic acid B from this plant showed even higher potency with an IC50 of 6.1 μg/mL. These findings highlight the plant's potential as a biological agent against the parasite.
Preparations
Myrsine coriacea subsp. coriacea is prepared as ethanolic extracts of the stem barks to evaluate its medicinal potential. In the provided research context, these specific preparations are used to test biological activities against parasitic strains. The study focuses on identifying active principles within such extracts to combat diseases like Leishmaniasis. By utilizing the stem barks in this manner, researchers can isolate compounds like myrsinoic acid B. This method of extraction serves as a critical step in determining the plant's effectiveness as an antiparasitic agent.
Parts used
Myrsine coriacea subsp. coriacea is a plant species that contains a specific part stem used in botanical research. Within the context of recent medicinal evaluations, various plant components have been tested for their potential antileishmanial activity. Researchers have focused on extracting active principles from different organs, including roots, leaves, and barks, to combat Leishmania parasites. The study highlights how these specialized plant parts can serve as sources for promising new antiparasitic agents. Ultimately, identifying these bioactive relationships is essential for developing effective treatments against parasitic diseases.